Although it was reported that cardiac Drp1 is undergoes more O-GlcNAcylation in type 2 diabetic mice [6], the link between Drp1 O-GlcNAcylation and AD pathology remains largely unknown. Here, DNM1L is linked to type 2 diabetes mellitus.